医疗教育培训网-中国较早，口碑很好的医疗教育培训考试移动平台，自营产品涵盖：住院医师、医师档案、绩效考核、医疗考试等。专业研发和服务团队，让全国所有医院用的放心！

创实互联,为三、四、五线城市量身打造移动互联网本地生活服务APP创业项目，为创业者提供完整的电商/外卖/配送/信息发布系统，APP+小程序+H5公众号三端合一。

济南迈克阀门科技有限公司是集产品研发设计、生产制造、销售服务为一体的阀门应用方案解决型公司。成立于2014年5月，投资10亿元，主要生产球铁、碳钢、铜、不锈钢等材质的闸阀、蝶阀、止回阀、过滤器、报警阀、水控阀、半球阀等系列产品。

杭州好风品牌策划公司是杭州知名品牌品牌战略咨询公司之一,专注产品策划、品牌策划、全案营销策划服务,杭州营销策划公司能快速帮助企业提升品牌影响力!咨询热线:186-6816-3757.

团盛新材料是一家专注高性能铝合金型材的开发应用及相关后续加工、配套塑料、压铸产品的生产与制造的全产业链集团公司，业务范围从高精尖的航天航空、到民用民生的智能家居、医疗、高铁、汽车等领域。

江阴市凯立得建设工程有限公司|土建,打桩,装潢,市政,门窗,租赁,土石方

新疆西北得力旗下

该站点未添加描述description...

该站点未添加描述description...

生物在线，生物谷网站旗下生物科研服务专业平台，生物在线围绕生物医药科研和开发领域，提供从各种仪器，试剂，耗材等产品，到技术服务方案等综合服务体系

WestVacBiopharmaisfoundedbyAcademicianWeiYuquanfromWestChinaHospitalofSichuanUniversity,togetherwith10scientistsfromStateKeyLaboratoryofBiotherapy(SKLB).ItsheadquarterislocatedintheInternationalBio-Town,Chengdu.TheCEOofWestVacBiopharmaisProf.WeiYuquan,whoistheAcademicianofChineseAcademyofSciencesaswellastheDirectorofStateKeyLaboratoryofBiotherapy.WestVaciscommittedtoexploringthelatestbiotherapytechnologiesformajordiseases,includinginfectiousdiseases,malignanttumors,cardiovasculardiseases,andsoon.IthasattachedgreatimportanceintheResearchandDevelopment(R&D)ofCOVID-19vaccineespeciallyandbuildingaCOVID-19vaccineproductionplatform.StateKeyLaboratoryofBiotherapy(SKLB)wasestablishedbytheMinistryofSciencesandTechnologyofChinain2005andbecameoneoftheNationalR&DPlatformsforNovelDrugsfoundedbytheMinistriesofSciencesandTechnologyaswellasthatofHealthofChinain2008.ItisalsosupportedbyNationalCollaborativeInnovationProgramandhasbecometheNationalCollaborativeInnovationCenterforBiotherapysince2013.WestChinaHospitalofSichuanUniversity，foundedin1892,istheNationalCenterforDiagnosisandTreatmentofSevereandCriticalDiseasesinWesternChina.Itisalsotheworld’slargestcomprehensivehospitalcomplexlocatedinonecampusarea.RelyingonthemedicalresourcesofStateKeyLaboratoryofBiotherapyandWestChinaMedicalCenter,WestVachasadoptedrecombinantproteinmethodologytodeveloptheCOVID-19vaccine.Becauseofthesafetyoftheproteinvaccine,itisalsotheonlyCOVID-19vaccineapprovedfortheuseinchildrenover3yearsoldinChina.ThevaccinewasapprovedbytheNationalMedicalProductsAdministrationforclinicaltrialsonAugust21,2020.PhaseI/IIclinicaltrialshavebeencompleted,andphaseIIIclinicaltrialsarebeingcarriedoutinNepal,Kenya,Japanandothercountries.Thevaccinetargetsthespikeproteinbindingdomain(S-RBD)ofSARS-CoV-2,producingneutralizingantibodiestoblockCOVID-19infectionofhumancells.TheresultwaspublishedonNature,theworld’sfamousscientificjournalonJuly29th,2020.IthasalsobeenthefirstpaperofCOVIDvaccinepublishedbyNaturesincethepandemicoutbreak.TheS-RBDgeneoftheCOVID-19virusisintroducedintotheinsectcells,whichwereusedasafactorytoproducehigh-qualityrecombinantvaccineproteinandthendoesrefinedpurification.Suchtechnologyiseasytobemass-producedandbroughttothemarket.WestVacBiopharmaiscommittedtobecomingtheworld`sleadingvaccineandimmunotherapyplatform.

该站点未添加描述description...